Infectious Disease Alert – June 1, 2006
June 1, 2006
View Issues
-
An Emerging Extended-Spectrum Triazole Antifungal: Noxafil® (Posaconazole)
Medical advances in recent years have resulted in an increased frequency of invasive fungal infections.1 Patients undergoing solid organ transplantation, HIV/AIDS treatment, and invasive surgical procedures are especially susceptible to fungal pathogens, and are more likely to experience recurrent fungal infections. -
Seroreversion in Patients Receiving Antiretrovirals During Early HIV Infection
This paper from the Gladstone Institute at the University of California, San Francisco represents a substudy of intensively studied patients who were enrolled in the Options Project. -
Amebic Encephalitis — More Common Than You Might Think
As part of the California Encephalitis Project (CEP), more than 250 serum samples from selected patients were screened for antibodies to amebic pathogens, particularly Balamuthia mandrillaris. Overall, the CEP has tested samples for > 1800 cases submitted for extensive testing in attempts to determine the etiology of encephalitis in patients without severe immunocompromise. -
Updates By Carol A. Kemper, MD, FACP
On my first walk through a redwood forest after moving to California, I came across numerous slimy yellow creatures along the trail that looked like snails without shells. These were banana slugs, creatures that are currently the official mascots of the University of Califonia, Santa Cruz. -
Pharmacology Watch: Gastric Acid Secretion and the Absorption of Thyroxine
Can Plavix Add to the Efficacy of Aspirin?; Prevention of Hypertension?; Estrogen Alternatives; FDA Actions -
Clinical Briefs in Primary Care supplement